Subnavigation

• Influenza
• Surveillance and monitoring
  • Updates
  • FluID
• GISRS and laboratory
  • FluNet
  • National Influenza Centres
  • WHO Collaborating Centres for influenza and Essential Regulatory Laboratories
  • WHO H5 Reference Laboratories
  • Antiviral susceptibility surveillance
  • WHO External Quality Assessment Project
  • Shipping and logistic activities
• PIP Framework
  • Advisory Group
  • Virus Sharing
  • Benefit Sharing
• Vaccines
  • Vaccine viruses
  • Vaccine use
• Patient care
  • Clinical management
  • Antivirals
• Human animal interface
  • Avian influenza in humans
  • Swine influenza in humans
• Public health preparedness
• Information resources
  • Research
  • Training
  • Publications

Candidate vaccine viruses and potency testing reagents for influenza A(H5N1)

• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 175kb
  24 January 2013

Previous summaries

• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 115kb
  8 March 2012
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 90kb
  16 January 2012
• Availability of a new A(H5N1) candidate vaccine virus (clade 2.3.2.1)
  16 January 2012
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 121kb
  15 November 2011
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 126kb
  7 November 2011
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 152kb
  16 September 2011
• Availability of a new recombinant A(H5N1) vaccine virus
  16 September 2011
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 152kb
  18 May 2011
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 129kb
  07 March 2011
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses*# and potency testing reagents
  pdf, 97kb
  07 January 2011
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 96kb
  18 November 2010
• Summary of status of development and availability of A(H5N1) candidate vaccine viruses and potency testing reagents
  pdf, 89kb
  03 August 2010
• Availability of a new recombinant A(H5N1) vaccine virus
  03 August 2010
• Status of development and availability of A(H5N1) candidate vaccine viruses
  pdf, 77kb
  07 June 2010
• Availability of a new recombinant A(H5N1) vaccine virus
  14 July 2010
• Availability of a new recombinant H5N1 vaccine virus
  June 2010
• Availability of a new recombinant H5N1 vaccine virus
  May 2009
• Availability of new recombinant H5N1 vaccine viruses
  March 2009
• Availability of new recombinant H5N1 vaccine virus
  10 September 2008
• Availability of new recombinant H5N1 vaccine virus
  21 December 2006
• Availability of new H5N1 prototype strain for influenza pandemic vaccine development
  June 2006
• Availability of new H5N1 prototype strain for influenza pandemic vaccine development
  May 2006
• Availability of new H5N1 prototype strain for influenza pandemic vaccine development
  March 2006
• Availability of H5N1 prototype strains for influenza pandemic vaccine development
  February 2005